Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 86

1.

Inflammation and insulin resistance.

Shoelson SE, Lee J, Goldfine AB.

J Clin Invest. 2006 Jul;116(7):1793-801. Review. Erratum in: J Clin Invest. 2006 Aug;116(8):2308.

PMID:
16823477
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Therapeutic approaches to target inflammation in type 2 diabetes.

Goldfine AB, Fonseca V, Shoelson SE.

Clin Chem. 2011 Feb;57(2):162-7. doi: 10.1373/clinchem.2010.148833. Epub 2010 Nov 22. Review.

PMID:
21098138
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Why do anti-inflammatory therapies fail to improve insulin sensitivity?

Gao ZG, Ye JP.

Acta Pharmacol Sin. 2012 Feb;33(2):182-8. doi: 10.1038/aps.2011.131. Epub 2011 Oct 31. Review.

PMID:
22036866
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

Recent advances in the relationship between obesity, inflammation, and insulin resistance.

Bastard JP, Maachi M, Lagathu C, Kim MJ, Caron M, Vidal H, Capeau J, Feve B.

Eur Cytokine Netw. 2006 Mar;17(1):4-12. Review.

PMID:
16613757
[PubMed - indexed for MEDLINE]
5.

Macrophages, immunity, and metabolic disease.

McNelis JC, Olefsky JM.

Immunity. 2014 Jul 17;41(1):36-48. doi: 10.1016/j.immuni.2014.05.010. Review.

PMID:
25035952
[PubMed - indexed for MEDLINE]
6.

Type 2 diabetes as an inflammatory disease.

Donath MY, Shoelson SE.

Nat Rev Immunol. 2011 Feb;11(2):98-107. doi: 10.1038/nri2925. Epub 2011 Jan 14. Review.

PMID:
21233852
[PubMed - indexed for MEDLINE]
7.

Toll-like receptors, inflammation, metabolism and obesity.

Fresno M, Alvarez R, Cuesta N.

Arch Physiol Biochem. 2011 Jul;117(3):151-64. doi: 10.3109/13813455.2011.562514. Epub 2011 May 23. Review.

PMID:
21599616
[PubMed - indexed for MEDLINE]
8.

Obesity, inflammation, and insulin resistance.

Shoelson SE, Herrero L, Naaz A.

Gastroenterology. 2007 May;132(6):2169-80. Review.

PMID:
17498510
[PubMed - indexed for MEDLINE]
9.

Potential role of salicylates in type 2 diabetes.

Rumore MM, Kim KS.

Ann Pharmacother. 2010 Jul-Aug;44(7-8):1207-21. doi: 10.1345/aph.1M483. Epub 2010 Jun 1. Review.

PMID:
20516365
[PubMed - indexed for MEDLINE]
10.

The role of inflammation and macrophage accumulation in the development of obesity-induced type 2 diabetes mellitus and the possible therapeutic effects of long-chain n-3 PUFA.

Oliver E, McGillicuddy F, Phillips C, Toomey S, Roche HM.

Proc Nutr Soc. 2010 May;69(2):232-43. doi: 10.1017/S0029665110000042. Epub 2010 Feb 17. Review.

PMID:
20158940
[PubMed - indexed for MEDLINE]
11.

Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity.

Heilbronn LK, Campbell LV.

Curr Pharm Des. 2008;14(12):1225-30. Review.

PMID:
18473870
[PubMed - indexed for MEDLINE]
12.

The cellular and signaling networks linking the immune system and metabolism in disease.

Osborn O, Olefsky JM.

Nat Med. 2012 Mar 6;18(3):363-74. doi: 10.1038/nm.2627. Review.

PMID:
22395709
[PubMed - indexed for MEDLINE]
13.

The inflammatory consequences of psychologic stress: relationship to insulin resistance, obesity, atherosclerosis and diabetes mellitus, type II.

Black PH.

Med Hypotheses. 2006;67(4):879-91. Epub 2006 Jun 15.

PMID:
16781084
[PubMed - indexed for MEDLINE]
14.

Immunity as a link between obesity and insulin resistance.

Kalupahana NS, Moustaid-Moussa N, Claycombe KJ.

Mol Aspects Med. 2012 Feb;33(1):26-34. doi: 10.1016/j.mam.2011.10.011. Epub 2011 Oct 21. Review.

PMID:
22040698
[PubMed - indexed for MEDLINE]
15.

The role of inflammatory cytokines in diabetes and its complications.

King GL.

J Periodontol. 2008 Aug;79(8 Suppl):1527-34. doi: 10.1902/jop.2008.080246. Review.

PMID:
18673007
[PubMed - indexed for MEDLINE]
16.

Monocyte chemotactic protein-1 and its role in insulin resistance.

Sell H, Eckel J.

Curr Opin Lipidol. 2007 Jun;18(3):258-62. Review.

PMID:
17495598
[PubMed - indexed for MEDLINE]
17.

Targeting type 2 diabetes.

Schwanstecher C, Schwanstecher M.

Handb Exp Pharmacol. 2011;(203):1-33. doi: 10.1007/978-3-642-17214-4_1. Review.

PMID:
21484565
[PubMed - indexed for MEDLINE]
18.

The evil axis of obesity, inflammation and type-2 diabetes.

Das A, Mukhopadhyay S.

Endocr Metab Immune Disord Drug Targets. 2011 Mar;11(1):23-31. Review.

PMID:
21348821
[PubMed - indexed for MEDLINE]
19.

Targeting adipose tissue inflammation to treat the underlying basis of the metabolic complications of obesity.

Goran MI, Alderete TL.

Nestle Nutr Inst Workshop Ser. 2012;73:49-60; discussion p61-6. doi: 10.1159/000341287. Epub 2012 Oct 29. Review.

PMID:
23128765
[PubMed - indexed for MEDLINE]
20.

[Inflammation as a factor of the pathogenesis of insulin resistance and type 2 diabetes].

Schwarz V.

Ter Arkh. 2009;81(10):74-80. Review. Russian.

PMID:
19947447
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk